Author Loeffler, Markus
-
2000 | Conference Abstract
Dose escalated BEACOPP chemotherapy improves failure free survival in advanced Hodgkin's disease: Updated results of the German Hodgkin's Lymphoma Study Group.
Diehl, V.; Franklin, J.; Sieber, M.; Hasenclever, D.; Wolf, J.; Engert, A. & Hermann, R. et al. (2000)
Blood, 96(11) pp. 576A-+.
Washington: Amer Soc Hematology.
Details WoS
-
2002 | Conference Abstract
Significant dose escalation of the CHOEP regimen in young patients with aggressive non Hodgkin's lymphoma is feasible: Results of a prospective randomized phase I/II trial.
Truemper, L. H.; Kloss, M.; Held, G.; Schmits, R.; Franke, A.; Berdel, W. E. & Fischer, T. et al. (2002)
Blood, 100(11) 44th Annual Meeting of the American-Society-of-Hematology, PHILADELPHIA, PENNSYLVANIA.
Washington: Amer Soc Hematology.
Details WoS
-
2002 | Conference Abstract
Mega-CHOEP repeated high dose therapy as treatment of aggressive NHL: Critical impact of time scheduling.
Glass, B.; Kloess, M.; Engert, A.; Berdel, W. E.; Metzner, B.; Truemper, L. H. & Loeffler, M. et al. (2002)
Blood, 100(11) 44th Annual Meeting of the American-Society-of-Hematology, PHILADELPHIA, PENNSYLVANIA.
Washington: Amer Soc Hematology.
Details WoS
-
2003 | Conference Abstract
Repeated high-dose therapy with rituximab followed by autologous stem cell transplantation (ASCT) as primary treatment of high-risk aggressive NHL.
Glass, B.; Kloess, M.; Engert, A.; Berdel, W. E.; Metzner, B.; Truemper, L. H. & Loeffler, M. et al. (2003)
Blood, 102(11) 45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA.
Washington: Amer Soc Hematology.
Details WoS
-
2003 | Journal Article
Practicability and acute haematological toxicity of 2-and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
Wunderlich, A.; Kloess, M.; Reiser, M.; Rudolph, C.; Truemper, L. H.; Bittner, S. & Schmalenberg, H. et al. (2003)
Annals of Oncology, 14(6) pp. 881-893. DOI: https://doi.org/10.1093/annonc/mdg249
Details DOI PMID PMC WoS
-
2004 | Conference Abstract
Early dose intensity is critical in patients with aggressive lymphoma: A randomized study comparing identical doses of cyclophosphamide, adriamycin, vincristine, etoposide, and prednisolone given as 4 or 6 cycles followed by repetitive transplantation of stem cells (Mega-CHOEP).
Glass, B.; Kloess, M.; Reiser, M.; Berdel, W. E.; Ho, A. D.; Truemper, L. H. & Loeffler, M. et al. (2004)
Blood, 104(11) 46th Annual Meeting of the American-Society-of-Hematology, San Diego, CA.
Washington: Amer Soc Hematology.
Details WoS
-
2004 | Conference Abstract
First analysis of the completed Mabthera International (MInT) trial in young patients with low-risk diffuse large B-cell lymphoma (DLBCL): Addition of rituximab to a CHOP-like regimen significantly improves outcome of all patients with the identification of a very favorable subgroup with IPI=O and no bulky disease.
Pfreundschuh, M.; Truemper, L. H.; Gill, D. S.; Osterborg, A.; Pettengell, R.; Trneny, M. & Imrie, K. et al. (2004)
Blood, 104(11) 46th Annual Meeting of the American-Society-of-Hematology, San Diego, CA.
Washington: Amer Soc Hematology.
Details WoS
-
2004 | Conference Abstract
Repetitive high-dose therapy with dose escalated CHOP plus Etoposide followed by autologous stem cell transplantation (Mega-CHOEP) in younger patients with primary diagnosis of aggressive NHL and elevated LDH at diagnosis: Final analysis
Schmitz, N.; Kloess, M.; Engert, A.; Berdel, W. E.; Metzner, B.; Truemper, L. H. & Loeffler, M. et al. (2004)
Blood, 104(11) 46th Annual Meeting of the American-Society-of-Hematology, San Diego, CA.
Washington: Amer Soc Hematology.
Details WoS
-
2004 | Conference Abstract
Nad(p)h oxidase and MRP genetic polymorphisms associate with doxorubicin-induced cardiotoxicity
Wojnowski, L.; Schlueter, G.; Vonhof, S.; Kulle, B.; Bickeboeller, H. ; Loeffler, M. & Pfreundschuh, M. et al. (2004)
Journal of Clinical Oncology, 22(14) 40th Annual Meeting of the American-Society-of-Clinical-Oncology, New Orleans, LA.
Alexandria: Amer Soc Clinical Oncology.
Details PMID PMC WoS
-
2004 | Conference Abstract
Association of NAD(P)H oxidase and MRP genetic polymorphisms with doxorubicin-induced cardiotoxicity
Wojnowski, L.; Schluter, G.; Vonhof, S.; Kulle, B.; Bickeboeller, H. ; Toliat, M. R. & Suk, E. K. et al. (2004)
Naunyn-Schmiedeberg s Archives of Pharmacology, 369 45th Spring Meeting of the German-Society-for-Experimental-and-Clinical-Pharmacology-and-Toxicology, Mainz, GERMANY.
New york: Springer.
Details WoS
-
2004 | Conference Abstract
NAD(P)H oxidase and MRP genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity
Schirmer, M. A.; Wojnowski, L.; Schluter, G.; Vonhof, S.; Kulle, B.; Bickeboeller, H. & Toliat, M. R. et al. (2004)
Circulation, 110(17) pp. 807-808. 77th Scientific Meeting of the American-Heart-Association, New Orleans, LA.
Philadelphia: Lippincott Williams & Wilkins.
Details WoS
-
2004 | Journal Article
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL
Pfreundschuh, M.; Truemper, L. H.; Kloess, M.; Schmits, R.; Feller, A. C.; Rudolph, C. & Reiser, M. et al. (2004)
Blood, 104(3) pp. 626-633. DOI: https://doi.org/10.1182/blood-2003-06-2094
Details DOI PMID PMC WoS
-
2004 | Journal Article
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL
Pfreundschuh, M.; Truemper, L. H.; Kloess, M.; Schmits, R.; Feller, A. C.; Rube, C. & Rudolph, C. et al. (2004)
Blood, 104(3) pp. 634-641. DOI: https://doi.org/10.1182/blood-2003-06-2095
Details DOI PMID PMC WoS
-
2005 | Conference Abstract
Dose escalated CHOP plus etoposide followed by repetitive autologous stem cell transplantation (MegaCHOEP) with or without rituximab for primary treatment of aggressive NHL.
Glass, B.; Kloess, M.; Reiser, M.; Metzner, B.; Truemper, L. H.; Loeffler, M. & Pfreundschuh, M. et al. (2005)
Blood, 106(11) 47th Annual Meeting of the American-Society-of-Hematology, Atlanta, GA.
Washington: Amer Soc Hematology.
Details WoS
-
2005 | Conference Abstract
Dose escalated CHOP plus etoposide and repetitive autologous stem cell transplantation (MegaCHOEP) with and without rituximab for primary treatment of aggressive NHL.
Glass, B.; Kloess, M.; Engert, A.; Berdel, W. E.; Metzner, B.; Tromper, L. & Loeffler, M. et al. (2005)
Journal of Clinical Oncology, 23(16) 41st Annual Meeting of the American-Society-of-Clinical-Oncology, Orlando, FL.
Alexandria: Amer Soc Clinical Oncology.
Details WoS
-
2005 | Conference Abstract
Interleukin-10 gene promoter polymorphisms in aggressive non-Hodgkin lymphoma
Kube, D.; Hua, T.; Kulle, B.; Gocht, D.; Kloess, M.; Brockmoeller, J. & Wojnowski, L. et al. (2005)
Annals of Oncology, 16 9th International Conference on Malignant Lymphoma, Lugano, SWITZERLAND.
Oxford: Oxford Univ Press.
Details WoS
-
2005 | Conference Abstract
Toxicity risk groups in aggressive NHL - Prognostic factors for hematotoxicity
Kloess, M.; Schmits, R.; Truemper, L. H.; Pfreundschuh, M. & Loeffler, M. (2005)
Annals of Oncology, 16 9th International Conference on Malignant Lymphoma, Lugano, SWITZERLAND.
Oxford: Oxford Univ Press.
Details WoS
-
2005 | Conference Abstract
Prognostic relevance of extrlymphatic involvement in aggressive lymphoma Results from a large randomized multicenter trial of the DSHNHL
Kempf, B.; Kloess, M.; Schmits, R.; Loeffler, M.; Truemper, L. H. & Pfreundschuh, M. (2005)
Annals of Oncology, 16 9th International Conference on Malignant Lymphoma, Lugano, SWITZERLAND.
Oxford: Oxford Univ Press.
Details WoS
-
2005 | Journal Article | Research Paper
NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity
Wojnowski, L.; Kulle, B.; Schirmer, M. ; Schlüter, G.; Schmidt, A.; Rosenberger, A. & Vonhof, S. et al. (2005)
Circulation, 112(24) pp. 3754-3762. DOI: https://doi.org/10.1161/CIRCULATIONAHA.105.576850
Details DOI PMID PMC WoS
-
2006 | Conference Abstract
Dose escalated CHOP plus etoposide with repetitive autologous stem cell transplantation as primary treatment for aggressive T-NHL: results of three consecutive phase I/II trials
Nickelsen, M.; Kloess, M.; Loeffler, M.; Glass, B.; Truemper, L. H.; Pfreundschuh, M. & Schmitz, N. (2006)
Bone Marrow Transplantation, 37 , Hamburg, GERMANY.
London: Nature Publishing Group.
Details WoS